Steven Cohen's ARCT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 63,845 shares of Arcturus Therapeutics Holdings Inc. (ARCT) worth $492,883, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ARCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 488,123 shares. Largest reduction occurred in Q4 2022, reducing 552,624 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Arcturus Therapeutics Holdings (ARCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arcturus Therapeutics Holdings (ARCT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -158,318 | Reduce 71.26% | 63,845 | $7.72 |
| Q4 2025 | +222,163 | New Buy | 222,163 | $6.13 |
| Q3 2025 | -6,154 | Sold Out | 0 | $0.00 |
| Q2 2025 | -4,163 | Reduce 40.35% | 6,154 | $13.01 |
| Q1 2025 | +10,317 | New Buy | 10,317 | $10.59 |
| Q3 2024 | -244,154 | Sold Out | 0 | $0.00 |
| Q2 2024 | -91,224 | Reduce 27.20% | 244,154 | $24.35 |
| Q1 2024 | +317,800 | Add 1807.94% | 335,378 | $33.77 |
| Q4 2023 | -317,700 | Reduce 94.76% | 17,578 | $31.53 |
| Q3 2023 | +330,875 | Add 7514.76% | 335,278 | $25.55 |
| Q2 2023 | -75,985 | Reduce 94.52% | 4,403 | $28.68 |
| Q1 2023 | +15,888 | Add 24.63% | 80,388 | $23.97 |
| Q4 2022 | -552,624 | Reduce 89.55% | 64,500 | $16.96 |
| Q3 2022 | -296,199 | Reduce 32.43% | 617,124 | $14.82 |
| Q2 2022 | +488,123 | Add 114.80% | 913,323 | $15.74 |
| Q1 2022 | +425,200 | New Buy | 425,200 | $26.96 |
| Q3 2020 | -223,013 | Sold Out | 0 | $0.00 |
| Q2 2020 | +223,013 | New Buy | 223,013 | $46.74 |
Steven Cohen's Arcturus Therapeutics Holdings Investment FAQs
Steven Cohen first purchased Arcturus Therapeutics Holdings Inc. (ARCT) in Q2 2020, acquiring 223,013 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Arcturus Therapeutics Holdings Inc. (ARCT) for 18 quarters since Q2 2020.
Steven Cohen's largest addition to Arcturus Therapeutics Holdings Inc. (ARCT) was in Q2 2022, adding 913,323 shares worth $14.38 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 63,845 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $492,883.
As of the Q1 2026 filing, Arcturus Therapeutics Holdings Inc. (ARCT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Arcturus Therapeutics Holdings Inc. (ARCT) was 913,323 shares, as reported at the end of Q2 2022.